Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries Restructuring Reserve Utilization by Quarter
Restructuring Reserve Utilization — Employee Termination ($M)
Teva Pharmaceutical Industries Restructuring Reserve Utilization: $53M in Q3 2026, up 26.2% from a year earlier.
Where the Q3 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: SEC Form 10-Q (0000818686-26-000006) ↗
Reported in SEC Form 10-K / Form 10-Q (XBRL & Footnotes).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Restructuring Reserve Utilization ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/restruct-utilized-emp
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?